NeoGenomics Company Profile (NASDAQ:NEO)

Analyst Ratings

Consensus Ratings for NeoGenomics (NASDAQ:NEO) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (7.41% upside)

Analysts' Ratings History for NeoGenomics (NASDAQ:NEO)
Show:
DateFirmActionRatingPrice TargetActions
7/9/2016Craig HallumReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2016BTIG ResearchReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Roth CapitalInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Benchmark Co.Boost Price TargetBuy$8.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Janney Montgomery ScottInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for NeoGenomics (NASDAQ:NEO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016Q216$0.03$61.07 millionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2016Q116($0.07)$0.03$57.00 million$59.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2016Q415$0.02($0.03)$26.46 million$27.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115($0.02)($0.01)$23.36 million$23.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414$0.01$0.02$24.30 million$25.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.01)($0.01)$22.43 million$23.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2014Q214$0.01$0.01$19.84 million$20.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2014Q413$0.02$0.04$17.80 million$18.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313$0.01$0.02$16.84 million$16.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.01$16.20 million$15.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NeoGenomics (NASDAQ:NEO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.01)($0.01)($0.01)
Q2 20161$0.01$0.01$0.01
Q3 20161$0.04$0.04$0.04
Q4 20161$0.05$0.05$0.05
(Data provided by Zacks Investment Research)

Dividends

Dividend History for NeoGenomics (NASDAQ:NEO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NeoGenomics (NASDAQ:NEO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/27/2016Oort Douglas M VanCEOSell481,387$8.73$4,202,508.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Steven A RossInsiderSell18,000$8.50$153,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Steven A RossInsiderSell15,000$8.22$123,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Steven C JonesVPSell177,745$8.21$1,459,286.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Steven A RossInsiderSell112,500$8.11$912,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016George CardozaCFOSell32,000$6.83$218,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016Oort Douglas M VanCEOSell450,000$7.10$3,195,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2016Alison L HannahDirectorBuy10,000$6.90$69,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Lynn A TetraultDirectorBuy3,500$7.72$27,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Robert J ShovlinCOOBuy6,550$7.75$50,762.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Steven C JonesVPSell385,000$8.09$3,114,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Bruce K CrowtherDirectorBuy6,400$7.81$49,984.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2014Robert H HorelVPSell32,389$4.21$136,357.69View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Robert H HorelVPSell62,893$4.20$264,150.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Michael T DentDirectorSell11,800$4.50$53,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014George CardozaCFOSell60,000$4.28$256,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2014Michael T DentDirectorSell33,200$4.51$149,732.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Robert P GaspariniInsiderSell100,000$3.49$349,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Robert GaspariniInsiderSell10,000$3.65$36,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2014Maher AlbitarInsiderBuy14,492$3.51$50,866.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014Michael T DentDirectorSell300,000$3.00$900,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2013Robert P GaspariniInsiderSell20,100$3.70$74,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013George CardozaCFOSell20,000$3.66$73,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2013Robert P GaspariniInsiderSell32,996$3.67$121,095.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Robert P GaspariniInsiderSell32,146$3.67$117,975.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2013Steven C JonesVPSell112,969$3.58$404,429.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2013Steven C JonesDirectorSell100,000$3.71$371,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NeoGenomics (NASDAQ:NEO)
DateHeadline
07/22/16 08:21 AMNeoGenomics, Inc. (NASDAQ:NEO): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 08:21 AMBrokers Issue Average Price Target Of 8.50 On NeoGenomics, Inc. (NEO) - Fiscal Standard
07/22/16 08:21 AMIs Buying All-time Stock Like NeoGenomics, Inc. a Winning Strategy? - Consumer Eagle
07/21/16 05:42 PMNeoGenomics, Inc. : half-yearly earnings release
07/20/16 08:20 AMNew Broker Ratings For NeoGenomics, Inc. (NEO) - FTSE News
07/20/16 08:20 AMEquity Roundup: Stock Performance Focus on NeoGenomics, Inc. (NASDAQ:NEO) - Press Telegraph
07/19/16 08:55 AMShare Performance Summary for: Neogenomics Inc. (NASDAQ:NEO) - Press Telegraph
07/19/16 08:55 AMNeogenomics Inc versus Pacific Biosciences of California Inc Head to Head Compare - CML News
07/18/16 03:04 PMNeoGenomics, Inc. – Value Analysis (NASDAQ:NEO) : July 18, 2016 -
07/17/16 04:49 PMShares Moving Down on the Week: Neogenomics Inc. (NASDAQ:NEO) - Engelwood Daily
07/17/16 09:40 AMNeogenomics Incorporated (NASDAQ:NEO) Sellers Increased By 8.74% Their Shorts - Consumer Eagle
07/15/16 10:13 AMNeoGenomics, Inc. (NASDAQ:NEO) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 10:13 AMLuminex Corporation versus Neogenomics Inc Head to Head Compare - CML News
07/14/16 05:42 PM4 Stocks To Watch: AG, NEO, TWLO, VUZI
07/14/16 08:59 AMAnalyst Target and Average Rating Watch: NeoGenomics, Inc. (NASDAQ:NEO) - Press Telegraph
07/13/16 10:06 AMLock Down Gains in Big Winners -
07/11/16 05:27 PMNeogenomics Incorporated (NASDAQ:NEO) Short Interest Increased By 8.74% - Consumer Eagle
07/11/16 05:27 PMOption Market: Neogenomics Inc Risk Hits An Elevated Level - CML News
07/11/16 10:01 AMStock on the Rise for the Quarter: Neogenomics Inc. (NASDAQ:NEO) - Engelwood Daily
07/11/16 10:01 AMStock Performance Rundown on: Neogenomics Inc. (NASDAQ:NEO) - Press Telegraph
07/11/16 07:24 AMNeoGenomics, Inc. breached its 50 day moving average in a Bullish Manner : NEO-US : July 11, 2016 -
07/08/16 05:30 PMIncreased Volatility on Shares of: Neogenomics Inc. (NASDAQ:NEO) - Engelwood Daily
07/08/16 05:30 PMAnalyst Update: Barracuda Networks Inc, Gogo Inc, and NeoGenomics, Inc. - Schaeffers Research (blog)
07/07/16 05:26 PMCompany Stock Focus for NeoGenomics, Inc. (NASDAQ:NEO): Which Way Will Shares Head? - Press Telegraph
07/07/16 05:26 PMCan NeoGenomics, Inc. (NASDAQ:NEO) Improve on the Earnings Front? - Engelwood Daily
07/06/16 05:38 PMNeoGenomics, Inc. (NEO) Updated Price Targets - FTSE News
07/06/16 10:01 AMStock Tracking Down This Month; Investor Alert on Neogenomics Inc. (NASDAQ:NEO) - Engelwood Daily
07/06/16 10:01 AMPerformance Recap and Target Perspective on NeoGenomics, Inc. (NASDAQ:NEO) - Press Telegraph
07/06/16 09:38 AMNeoGenomics Deal With GE's Clarient 6 Months Later: Boom or Bust? -
07/05/16 05:11 PMBroker Outlook For The Week Ahead NeoGenomics, Inc. (NEO) - Fiscal Standard
07/05/16 05:11 PMShare Performance Recap for: Neogenomics Inc. (NASDAQ:NEO) - Press Telegraph
07/05/16 05:11 PMNeoGenomics Inc.: NeoGenomics Schedules its Q2 2016 Earnings Release for July 26, 2016 - The Wall Street Transcript
07/05/16 06:21 AMNeoGenomics Schedules its Q2 2016 Earnings Release for July 26, 2016 - [at noodls] - FT. MYERS, Fla., July 5, 2016 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its second quarter 2016 financial results on Tuesday July 26, 2016. ... This is an ...
07/01/16 08:14 AMCovering the Bases on NeoGenomics, Inc. (NASDAQ:NEO): Where is the Stock Going? - Press Telegraph
06/29/16 05:17 PMEquity Research and Technical Review on NeoGenomics, Inc. (NASDAQ:NEO) - Press Telegraph
06/27/16 07:38 AMNeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : June 27, 2016 -
06/25/16 04:58 PMNeoGenomics, Inc. (NASDAQ:NEO) Earnings Glance and Target Price Review - Engelwood Daily
06/25/16 04:58 PMWhat's Propelling NeoGenomics, Inc. to Decline So Much? - Engelwood Daily
06/23/16 08:07 AMNeogenomics Inc. (NasdaqCM:NEO) Stock Momentum Hits Strength - CML News
06/20/16 01:55 PMETF’s with exposure to NeoGenomics, Inc. : June 20, 2016 -
06/20/16 07:03 AMCompany Shares of NeoGenomics Drops by -5.12% - Trade Calls
06/16/16 09:38 AMRecently Issued Stock Ratings For NeoGenomics, Inc. (NEO) - Fiscal Standard
06/16/16 08:14 AMBet on These 5 Stocks with Upgraded Broker Ratings -
06/15/16 08:54 AMNeogenomics (NEO) Sees Hammer Chart Pattern: Time to Buy? -
06/15/16 07:29 AMNeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : June 15, 2016 -
06/13/16 08:20 AMTraders Spotlight: Novartis AG (NYSE:NVS) , NeoGenomics, Inc. (NASDAQ:NEO) - Street Updates
06/09/16 12:28 PMETF’s with exposure to NeoGenomics, Inc. : June 9, 2016 -
06/08/16 05:49 PMForm 8-K NEOGENOMICS INC For: Jun 07 - StreetInsider.com
06/08/16 11:12 AMNEOGENOMICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial Stat -
06/08/16 09:12 AMNeoGenomics, Inc. :NEO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 -

Social

About NeoGenomics

NeoGenomics logoNeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company offers testing services, which includes Cytogenetics testing, which is the study of normal and abnormal chromosomes and their relationship to disease; fluorescence in-situ hybridization (FISH) testing, which is a branch of cancer genetics that focuses on detecting and locating the presence or absence of specific deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which is a way to measure the characteristics of cell populations; immunohistochemistry (IHC) testing, which is a process of identifying cell proteins in a tissue section utilizing the principle of antibodies binding specifically to in biological tissues., and molecular testing, which is a cancer diagnostic tool focusing on the analysis of DNA and ribonucleic acid (RNA), as well as the structure and function of genes at a molecular level.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NEO
  • CUSIP:
Key Metrics:
  • Previous Close: $9.29
  • 50 Day Moving Average: $8.58
  • 200 Day Moving Average: $7.49
  • P/E Ratio: N/A
  • P/E Growth: 3.88
  • Market Cap: $717.96M
  • Beta: 1.36
  • Current Year EPS Consensus Estimate: $0.08 EPS
  • Next Year EPS Consensus Estimate: $0.19 EPS
Additional Links:
NeoGenomics (NASDAQ:NEO) Chart for Saturday, July, 23, 2016